Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Rekor Systems | REKR | Nov 25, 2024 | 0.95 | -0.96 |
Relay Therapeutics | RLAY | Nov 25, 2024 | 4.86 | +2.32 |
Reliance | RS | Nov 25, 2024 | 323.08 | +1.19 |
Reliance Global | RELI | Nov 25, 2024 | 1.60 | +24.03 |
Relmada Therapeutics | RLMD | Nov 25, 2024 | 2.76 | -1.43 |
RELX ADR | RELX | Nov 25, 2024 | 46.57 | -0.39 |
Remitly Global | RELY | Nov 25, 2024 | 20.52 | -2.47 |
Renaissance Ipo ETF | IPO | Nov 25, 2024 | 47.00 | +1.91 |
RenaissanceRe | RNR | Nov 25, 2024 | 279.67 | +2.86 |
RenaissanceRe G Pref | RNR-G | Nov 25, 2024 | 18.23 | +0.44 |
RenaissanceRe Holding F Pref | RNR-F | Nov 25, 2024 | 24.58 | +0.41 |
Renalytix ADR | RNLX | Nov 25, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 25, 2024 | 38.62 | +1.90 |
ReNew Energy Global A Shares | RNW | Nov 25, 2024 | 6.13 | +4.07 |
Renn Fund | RCG | Nov 25, 2024 | 2.77 | +2.59 |
Renovaro Biosciences | RENB | Nov 25, 2024 | 0.50 | -3.66 |
RenovoRx | RNXT | Nov 25, 2024 | 1.21 | -6.20 |
Rent The Runway A | RENT | Nov 25, 2024 | 10.01 | +4.27 |
Rentokil Initial ADR | RTO | Nov 25, 2024 | 26.39 | +1.58 |
Repare Therapeutics | RPTX | Nov 25, 2024 | 3.05 | +8.54 |
Repay A | RPAY | Nov 25, 2024 | 8.20 | +1.86 |
Repligen | RGEN | Nov 25, 2024 | 146.06 | +2.44 |
Replimune Group | REPL | Nov 25, 2024 | 13.26 | -11.19 |
ReposiTrak | TRAK | Nov 25, 2024 | 22.60 | -1.57 |
Republic Bancorp A | RBCAA | Nov 25, 2024 | 77.83 | +0.27 |
Republic Services | RSG | Nov 25, 2024 | 217.86 | +0.49 |
Research Frontiers | REFR | Nov 25, 2024 | 1.93 | +3.21 |
Research Solutions | RSSS | Nov 25, 2024 | 3.36 | +3.38 |
Reservoir Media | RSVR | Nov 25, 2024 | 9.15 | -2.97 |
ReShape Lifesciences | RSLS | Nov 25, 2024 | 5.75 | +3.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.